Literature DB >> 12145328

The multidrug transporter, P-glycoprotein, actively mediates cholesterol redistribution in the cell membrane.

Alexia Garrigues1, Alexandre E Escargueil, Stephane Orlowski.   

Abstract

P-glycoprotein (P-gp) is a plasma membrane ATP-binding cassette transporter, responsible for multidrug resistance in tumor cells. P-gp catalyzes the ATP hydrolysis-dependent efflux of numerous amphiphilic compounds of unrelated chemical structures. In the absence of any identified substrate, P-gp exhibits an apparently futile, basal ATPase activity. By using native membrane vesicles containing high amounts of P-gp, we show here that (i) this basal ATPase activity is tightly dependent on the presence of cholesterol in the membrane; (ii) the stimulation of P-gp ATPase activity by drugs transported by P-gp is higher in the absence than in the presence of cholesterol and, conversely, the stimulation of P-gp ATPase activity by cholesterol is higher in the absence than in the presence of known P-gp substrates; (iii) P-gp mediates the ATP-dependent relocation of cholesterol from the cytosolic leaflet to the exoplasmic leaflet of the plasma membrane; and (iv) the decrease of the cholesterol dependence of P-gp ATPase activity induced by known P-gp substrates is correlated with the inhibition of the ATP-dependent cholesterol redistribution within the membrane. These data are highly evocative of a coupling between the basal ATPase activity of P-gp and its intramembrane cholesterol-redistribution function, and they are fully consistent with the possibility that P-gp may actively translocate cholesterol in the membrane. Finally, this P-gp-mediated cholesterol redistribution in the cell membrane makes it likely that P-gp contributes in stabilizing the cholesterol-rich microdomains, rafts and caveolae, and that it is involved in the regulation of cholesterol trafficking in cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12145328      PMCID: PMC124917          DOI: 10.1073/pnas.162366399

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  P-glycoprotein is localized in caveolae in resistant cells and in brain capillaries.

Authors:  M Demeule; J Jodoin; D Gingras; R Béliveau
Journal:  FEBS Lett       Date:  2000-01-28       Impact factor: 4.124

2.  Overexpression of MDR1 in an intestinal cell line results in increased cholesterol uptake from micelles.

Authors:  T G Tessner; W F Stenson
Journal:  Biochem Biophys Res Commun       Date:  2000-01-19       Impact factor: 3.575

Review 3.  Multidrug resistance: a role for cholesterol efflux pathways?

Authors:  M Liscovitch; Y Lavie
Journal:  Trends Biochem Sci       Date:  2000-11       Impact factor: 13.807

4.  ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport.

Authors:  J Klucken; C Büchler; E Orsó; W E Kaminski; M Porsch-Ozcürümez; G Liebisch; M Kapinsky; W Diederich; W Drobnik; M Dean; R Allikmets; G Schmitz
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

Review 5.  ABC transporters in lipid transport.

Authors:  P Borst; N Zelcer; A van Helvoort
Journal:  Biochim Biophys Acta       Date:  2000-06-26

6.  Absence of cooperativity for MgATP and verapamil effects on the ATPase activity of P-glycoprotein containing membrane vesicles.

Authors:  M Garrigos; J Belehradek; L M Mir; S Orlowski
Journal:  Biochem Biophys Res Commun       Date:  1993-11-15       Impact factor: 3.575

Review 7.  Cholesterol and caveolae: structural and functional relationships.

Authors:  C J Fielding; P E Fielding
Journal:  Biochim Biophys Acta       Date:  2000-12-15

8.  Phospholipid flippase activity of the reconstituted P-glycoprotein multidrug transporter.

Authors:  Y Romsicki; F J Sharom
Journal:  Biochemistry       Date:  2001-06-12       Impact factor: 3.162

9.  A two-step mechanism for free cholesterol and phospholipid efflux from human vascular cells to apolipoprotein A-1.

Authors:  P E Fielding; K Nagao; H Hakamata; G Chimini; C J Fielding
Journal:  Biochemistry       Date:  2000-11-21       Impact factor: 3.162

10.  Effects of cholesterol and enantiomeric cholesterol on P-glycoprotein localization and function in low-density membrane domains.

Authors:  G D Luker; C M Pica; A S Kumar; D F Covey; D Piwnica-Worms
Journal:  Biochemistry       Date:  2000-07-04       Impact factor: 3.162

View more
  46 in total

Review 1.  The plasma membrane as a capacitor for energy and metabolism.

Authors:  Supriyo Ray; Adam Kassan; Anna R Busija; Padmini Rangamani; Hemal H Patel
Journal:  Am J Physiol Cell Physiol       Date:  2015-11-25       Impact factor: 4.249

2.  Decrease of P-glycoprotein activity in K562/ADR cells by MbetaCD and filipin and lack of effect induced by cholesterol oxidase indicate that this transporter is not located in rafts.

Authors:  Paiboon Reungpatthanaphong; Carole Marbeuf-Gueye; Laurence Le Moyec; Milena Salerno; Arlette Garnier-Suillerot
Journal:  J Bioenerg Biomembr       Date:  2004-12       Impact factor: 2.945

3.  Host cell P-glycoprotein is essential for cholesterol uptake and replication of Toxoplasma gondii.

Authors:  Iveta Bottova; Adrian B Hehl; Sasa Stefanić; Gemma Fabriàs; Josefina Casas; Elisabeth Schraner; Jean Pieters; Sabrina Sonda
Journal:  J Biol Chem       Date:  2009-04-22       Impact factor: 5.157

4.  Role of the ABC transporter Mdr49 in Hedgehog signaling and germ cell migration.

Authors:  Girish Deshpande; Diane Manry; Nicholas Jourjine; Vladic Mogila; Henny Mozes; Tzofia Bialistoky; Offer Gerlitz; Paul Schedl
Journal:  Development       Date:  2016-04-27       Impact factor: 6.868

5.  Transintestinal transport of the anti-inflammatory drug 4F and the modulation of transintestinal cholesterol efflux.

Authors:  David Meriwether; Dawoud Sulaiman; Alan Wagner; Victor Grijalva; Izumi Kaji; Kevin J Williams; Liqing Yu; Spencer Fogelman; Carmen Volpe; Steven J Bensinger; G M Anantharamaiah; Ishaiahu Shechter; Alan M Fogelman; Srinivasa T Reddy
Journal:  J Lipid Res       Date:  2016-05-19       Impact factor: 5.922

6.  Novel delivery system enhances efficacy of antiretroviral therapy in animal model for HIV-1 encephalitis.

Authors:  Timothy J Spitzenberger; David Heilman; Casey Diekmann; Elena V Batrakova; Alexander V Kabanov; Howard E Gendelman; William F Elmquist; Yuri Persidsky
Journal:  J Cereb Blood Flow Metab       Date:  2006-10-25       Impact factor: 6.200

Review 7.  ABCG transporters: structure, substrate specificities and physiological roles : a brief overview.

Authors:  Saroj Velamakanni; Shen L Wei; Tavan Janvilisri; Hendrik W van Veen
Journal:  J Bioenerg Biomembr       Date:  2007-12       Impact factor: 2.945

8.  Associations of ABCB1 and IL-10 genetic polymorphisms with sirolimus-induced dyslipidemia in renal transplant recipients.

Authors:  Wai-Johnn Sam; Christine E Chamberlain; Su-Jun Lee; Joyce A Goldstein; Douglas A Hale; Roslyn B Mannon; Allan D Kirk; Yuen Yi Hon
Journal:  Transplantation       Date:  2012-11-15       Impact factor: 4.939

9.  P-glycoprotein in proteoliposomes with low residual detergent: the effects of cholesterol.

Authors:  Karsten Bucher; Sara Belli; Heidi Wunderli-Allenspach; Stefanie D Krämer
Journal:  Pharm Res       Date:  2007-05-12       Impact factor: 4.200

10.  Do MDR1 and SLCO1B1 polymorphisms influence the therapeutic response to atorvastatin? A study on a cohort of Egyptian patients with hypercholesterolemia.

Authors:  Mona F Shabana; Amal A Mishriki; Marianne Samir M Issac; Sameh W G Bakhoum
Journal:  Mol Diagn Ther       Date:  2013-10       Impact factor: 4.074

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.